Absence of PERV infection in baboons after transgenic porcine liver perfusion.

[1]  I M Sauer,et al.  Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells , 2003, Xenotransplantation.

[2]  Y. Yamaoka,et al.  Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primates , 2003, Transplantation.

[3]  D. Salomon,et al.  Porcine Endogenous Retrovirus Infects but Does Not Replicate in Nonhuman Primate Primary Cells and Cell Lines , 2002, Journal of Virology.

[4]  U. Martin,et al.  Pig endogenous retroviruses and xenotransplantation , 2002, Xenotransplantation.

[5]  B. Lapin,et al.  Absence of PERV specific humoral immune response in baboons after transplantation of porcine cells or organs , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  L. Martignat,et al.  Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice , 2002, Diabetologia.

[7]  R. Kurth,et al.  Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. , 2002, Transplant immunology.

[8]  G. Mazariegos,et al.  Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. , 2002, Transplantation.

[9]  G. Mazariegos,et al.  Safety Observations in Phase I Clinical Evaluation of the Excorp Medical Bioartificial Liver Support System after the First Four Patients , 2001, ASAIO journal.

[10]  J. Denner,et al.  Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. , 2001, Virology.

[11]  Y. Yamaoka,et al.  Influence of extracorporeal porcine liver perfusion on nonhuman primates: Minimizing hemolysis improves subsequent survival , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  W. Heneine,et al.  LACK OF CROSS-SPECIES TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUS INFECTION TO NONHUMAN PRIMATE RECIPIENTS OF PORCINE CELLS, TISSUES, OR ORGANS1 , 2001, Transplantation.

[13]  K. Boller,et al.  Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. , 2001, The Journal of general virology.

[14]  B. Lapin,et al.  Long-term monitoring of xenotransplanted baboons: no evidence for pig endogenous retrovirus transmission. , 2001, Transplantation proceedings.

[15]  Prof. Dr. med. Gustav Steinhoff,et al.  Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerism , 2001, Transplant international : official journal of the European Society for Organ Transplantation.

[16]  D. Sudan,et al.  EXTRACORPOREAL LIVER PERFUSION USING HUMAN AND PIG LIVERS FOR ACUTE LIVER FAILURE , 2000, Transplantation.

[17]  B. Torbett,et al.  Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice , 2000, Nature.

[18]  Y Takeuchi,et al.  Infection of Nonhuman Primate Cells by Pig Endogenous Retrovirus , 2000, Journal of Virology.

[19]  Y. Takeuchi,et al.  Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV) , 2000, Xenotransplantation.

[20]  J. Banchereau,et al.  Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. , 2000, Transplantation.

[21]  W. Heneine,et al.  Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. , 1999, Science.

[22]  S. Satoh,et al.  Evaluation of ammonia and lidocaine clearance, and galactose elimination capacity of xenoperfused pig livers using a pharmacokinetic analysis. , 1999, Transplantation.

[23]  D H Persing,et al.  Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. , 1999, Transplantation.

[24]  R. Weiss,et al.  Host Range and Interference Studies of Three Classes of Pig Endogenous Retrovirus , 1998, Journal of Virology.

[25]  A. Demetriou,et al.  Artificial liver: review and Cedars-Sinai experience. , 1998, Journal of hepato-biliary-pancreatic surgery.

[26]  Gustav Steinhoff,et al.  Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells , 1998, The Lancet.

[27]  H. Shinohara,et al.  Humoral injury in porcine livers perfused with human whole blood. , 1997, Transplantation.

[28]  R. Weiss,et al.  Two sets of human-tropic pig retrovirus , 1997, Nature.

[29]  Yasuhiro Takeuchi,et al.  Infection of human cells by an endogenous retrovirus of pigs , 1997, Nature Medicine.

[30]  H. Shinohara,et al.  Successful long-term xenoperfusion of the pig liver: continuous administration of prostaglandin E1 and insulin. , 1997, Transplantation.

[31]  Y. Kamiyama,et al.  Clinical experience of postoperative hepatic failure treatment with pig or baboon liver cross-hemodialysis with an interposed membrane. , 1982, Artificial organs.

[32]  E. Dupont,et al.  Letter: One-hour biopsy and kidney transplantation. , 1974, Lancet.

[33]  G. Abouna,et al.  TREATMENT OF HEPATIC COMA BY EXTRACORPOREAL PIG-LIVER PERFUSION , 1969 .

[34]  B. Eiseman,et al.  Heterologous liver perfusion in treatment of hepatic failure. , 1965, Annals of surgery.